Evidence map›Paper›PMID 32195352›Full record

ArticleScience advances2020

Tumor cell-organized fibronectin maintenance of a dormant breast cancer population.

Lauren E Barney, Christopher L Hall, Alyssa D Schwartz, Akia N Parks, Christopher Sparages, Sualyneth Galarza, Manu O Platt, Arthur M Mercurio, Shelly R Peyton

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 114 papers.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed
13.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 150 citations in OpenAlex.

  1. Article
  2. Review
  3. Mechanisms of breast cancer dormancy in bone metastasis.Clinical & experimental metastasis · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Lauren E BarneyDepartment of Chemical Engineering, University of Massachusetts, Amherst, Amherst, MA 01003, USA.
Christopher L HallDepartment of Chemical Engineering, University of Massachusetts, Amherst, Amherst, MA 01003, USA.
Alyssa D SchwartzDepartment of Chemical Engineering, University of Massachusetts, Amherst, Amherst, MA 01003, USA.
Akia N ParksWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology/Emory University, Atlanta, GA 30332, USA.
Christopher SparagesDepartment of Chemical Engineering, University of Massachusetts, Amherst, Amherst, MA 01003, USA.ORCID 0000-0002-9518-5954
Sualyneth GalarzaDepartment of Chemical Engineering, University of Massachusetts, Amherst, Amherst, MA 01003, USA.
Manu O PlattWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology/Emory University, Atlanta, GA 30332, USA.ORCID 0000-0001-6390-4320
Arthur M MercurioDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.ORCID 0000-0003-2762-7519
Shelly R PeytonDepartment of Chemical Engineering, University of Massachusetts, Amherst, Amherst, MA 01003, USA.ORCID 0000-0002-7364-8727
University of Massachusetts Amherst · USGeorgia Institute of Technology · USUniversity of Massachusetts Chan Medical School · US

Funding

Research Training Program Plan on Cell and Tissue Engineering (CTEng)T32GM008433 · NIGMS · GEORGIA INSTITUTE OF TECHNOLOGY · PI GARCIA, ANDRES J · 1991 to 2021
$7.1M
CHEMISTRY-BIOLOGY INTERFACE PREDOCTORAL TRAINING GRANTST32GM008515 · NIGMS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI THOMPSON, LYNMARIE K. · 1995 to 2020
$4.3M
VEGF Signaling in Mammary TumorigenesisR01CA168464 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MERCURIO, ARTHUR M · 2012 to 2021
$3.7M
Tissue-specific stem cells and breast cancer tissue tropism in bioengineered microenvironmentsDP2CA186573 · NCI · UNIVERSITY OF MASSACHUSETTS AMHERST · PI PEYTON, SHELLY R. · 2013 to 2015
$2.6M
Integrin splicing and cancer stem cell fateR01CA203439 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MERCURIO, ARTHUR M · 2016 to 2020
$1.9M
NCI NIH HHS DP2 CA186573NCI NIH HHS R01 CA168464NCI NIH HHS R01 CA203439NIGMS NIH HHS T32 GM008433NIGMS NIH HHS T32 GM008515
6 · The paper itself

Abstract

Tumors can undergo long periods of dormancy, with cancer cells entering a largely quiescent, nonproliferative state before reactivation and outgrowth. To understand the role of the extracellular matrix (ECM) in regulating tumor dormancy, we created an in vitro cell culture system with carefully controlled ECM substrates to observe entrance into and exit from dormancy with live imaging. We saw that cell populations capable of surviving entrance into long-term dormancy were heterogeneous, containing quiescent, cell cycle-arrested, and actively proliferating cells. Cell populations capable of entering dormancy formed an organized, fibrillar fibronectin matrix via α

Indexed as

Breast NeoplasmsFemaleFibronectinsHumansIntegrin alpha5beta1Integrin alphaVbeta3Matrix Metalloproteinase 2MCF-7 CellsNeoplasm ProteinsFibronectinsIntegrin alpha5beta1Integrin alphaVbeta3Matrix Metalloproteinase 2MMP2 protein, humanNeoplasm Proteins

Identifiers

PMID32195352
PMCPMC7065904
OpenAlexW3011961818

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.